LOS ANGELES, Aug. 17, 2006 (PRIMEZONE) -- Universal Detection Technology (OTCBB:UDTT) (www.udetection.com) (FWB:PO8) commented today on the recent death of a man via Anthrax. On August 16, 2006 the newspaper Guardian Unlimited reported of a 50-year-old man who died from blood poisoning in July, but subsequent tests have shown that the bacterium was the likely cause of his death. The man’s home has been sealed off and investigators are examining if there are any risks of high levels of deadly spores in the environment.
The article included a discussion with the Scottish National Party MSP Christine Grahame who noted that NHS Borders had assured her that the man's family was receiving preventative treatment and counseling. She noted that it is has been 30 years since the last Anthrax death in the UK. Anthrax is curable if treated quickly with antibiotics. When the victim is not treated quickly enough, as in this case, he dies very quickly. Health Protection Scotland, the agency responsible for tackling outbreaks of infectious disease, was reviewing visitors to the man's home to assess them for the risk of infection.
A copy of the article can be viewed at: http://www.udetection.com/08-16-06-Guardian%20Unlimited-Man%20Killed%20by%20Anthrax.htm
"One of the most dangerous attributes of the anthrax bacteria is its long incubation period of up to 5 days. People can be affected and not know it until the toxins are already in the system and antibiotics are useless in treating the affected population," said Nima Montazeri, UDTT's Vice President. "That is exactly why we believe that early detection is the most important factor in reducing casualties of a potential anthrax attack. If the spores are detected early enough in the air, authorities can identify those who have potentially been affected and administer antibiotics before it's too late," he added.
About Universal Detection Technology
Universal Detection Technology (UDTT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Management believes that the Company's technology, together with third party technologies, has positioned it to capitalize on opportunities related to Homeland Security. Universal Detection Technology, in cooperation with NASA's Jet Propulsion Laboratory (JPL) has developed a bio-terror 'smoke' detector, which combines JPL's spore detection technology with UDTT's aerosol capture device. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt; our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market; our ability to commercially produce our products on a profitable basis; commercial acceptance of our products; product price volatility; product demand; market competition and general economic conditions and; other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.